… is highly inflammatory and partly damaged in severe COVID-19. … and diffuse distribution in
COVID-19 lungs. The correlation of … to damage and recruitment of inflammatory cells, further …

… inflammation, are emerging clinical features of COVID-19. We present a framework for
mechanisms of thrombosis in COVID-19 … signaling and subsequent inflammation and tissue injury. …

… of thrombosis seen clinically in COVID-19 … COVID-19 in areas associated with microthrombosis,
suggesting that endothelial damage and inflammation may directly underlie thrombus …

… we discuss COVID-19 and its implications for thrombosis and … in the inflammatory response
to infection in COVID-19 is … , representing a systemic inflammatory response syndrome from …

… abnormalities reported in COVID-19, discuss the thrombosis, and inflammation-driven …
impact of thrombotic and inflammatory processes on the progression and prognosis of COVID-19, …

… inflammation and thrombosis drives thrombotic diseases. We focus on the huge potential of
anti-inflammatory … in patients with COVID-19, linking inflammation and thrombosis 92,93 . …

… Proposed mechanisms of immunothrombosis in COVID-19 and the interactions of the
inflammation and coagulation systems. Direct SARS-CoV-2 – platelet interaction results in high …

… has provided evidence for a pathogenic link between inflammation and thrombosis. The
major features in the lungs of COVID‐19 patients comprised primary inflammatory thrombosis …

… COVID-19 is associated with an inflammatory state and a coagulopathy that are associated
with high rates of venous and arterial thrombosis, … arterial thrombotic events, and 19 patients (…

… activation in moderate COVID-19 patients compared with mild COVID-19 patients. First, we
… a higher inflammatory state in moderate COVID-19 patients than mild COVID-19 patients. …